Gilead Sciences (GILD) Tops Q1 EPS by 4c; maintains guidance
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $135.77 +2.04%
Financial Fact:
Provision for income taxes: 951M
Today's EPS Names:
WPRT, ITRG, ALM, More
Financial Fact:
Provision for income taxes: 951M
Today's EPS Names:
WPRT, ITRG, ALM, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q1 EPS of $1.81, $0.04 better than the analyst estimate of $1.77. Revenue for the quarter came in at $6.67 billion versus the consensus estimate of $6.78 billion.
GUIDANCE:
Gilead Sciences sees FY2025 EPS of $7.70-$8.10, versus the consensus of $7.95. Gilead Sciences sees FY2025 revenue of $28.2-28.6 billion, versus the consensus of $28.729 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westport Fuel Systems (WPRT) Misses Q2 EPS by 64c
- National CineMedia (NCMI) Misses Q2 EPS by 7c
- Kyverna Therapeutics, Inc. (KYTX) Tops Q2 EPS by 45c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
